| Christin Marie Giordano Mcauliffe, MD | |
|
1617 Williams Dr, Murfreesboro, TN 37129-3285 | |
| (615) 890-5484 | |
| Not Available |
| Full Name | Christin Marie Giordano Mcauliffe |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 8 Years |
| Location | 1617 Williams Dr, Murfreesboro, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679894034 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 60683 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fmc Dialysis Assoc. Of Smyrna | Smyrna, TN | Dialysis facility |
| Dci Murfreesboro | Murfreesboro, TN | Dialysis facility |
| Dialysis Assoc. Of Murfreesboro-ht | Murfreesboro, TN | Dialysis facility |
| Saint Thomas Rutherford Hospital | Murfreesboro, TN | Hospital |
| Tristar Stonecrest Medical Center | Smyrna, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nephrology Associates, Pc | 0840282000 | 55 |
News Archive
The largest analysis of its kind has found that Caucasians are much more likely that people in other racial/ethnic groups to develop a rare bone and soft tissue cancer called Ewing's sarcoma. In addition, among Caucasians with this cancer, men are more likely to die than women.
PharmaIN Corporation and LAT Pharma LLC today announced that the US Food and Drug Administration (FDA) has granted their request for orphan-drug designation for terlipressin for the treatment of ascites due to all etiologies except for cancer.
Ardea Biosciences, Inc. announced positive results from two clinical studies of RDEA594 in combination with currently marketed drugs for the treatment of gout patients, febuxostat (Uloric®) and allopurinol.
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing extended-release tablets containing 2.5mg, 5mg and 10mg Felodipine, which are used in treating hypertension.
› Verified 1 days ago
| Entity Name | Nephrology Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700878360 PECOS PAC ID: 0840282000 Enrollment ID: O20040330001670 |
News Archive
The largest analysis of its kind has found that Caucasians are much more likely that people in other racial/ethnic groups to develop a rare bone and soft tissue cancer called Ewing's sarcoma. In addition, among Caucasians with this cancer, men are more likely to die than women.
PharmaIN Corporation and LAT Pharma LLC today announced that the US Food and Drug Administration (FDA) has granted their request for orphan-drug designation for terlipressin for the treatment of ascites due to all etiologies except for cancer.
Ardea Biosciences, Inc. announced positive results from two clinical studies of RDEA594 in combination with currently marketed drugs for the treatment of gout patients, febuxostat (Uloric®) and allopurinol.
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing extended-release tablets containing 2.5mg, 5mg and 10mg Felodipine, which are used in treating hypertension.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christin Marie Giordano Mcauliffe, MD 1617 Williams Dr Ste 200, Murfreesboro, TN 37129-3287 Ph: (615) 890-5484 | Christin Marie Giordano Mcauliffe, MD 1617 Williams Dr, Murfreesboro, TN 37129-3285 Ph: (615) 890-5484 |
News Archive
The largest analysis of its kind has found that Caucasians are much more likely that people in other racial/ethnic groups to develop a rare bone and soft tissue cancer called Ewing's sarcoma. In addition, among Caucasians with this cancer, men are more likely to die than women.
PharmaIN Corporation and LAT Pharma LLC today announced that the US Food and Drug Administration (FDA) has granted their request for orphan-drug designation for terlipressin for the treatment of ascites due to all etiologies except for cancer.
Ardea Biosciences, Inc. announced positive results from two clinical studies of RDEA594 in combination with currently marketed drugs for the treatment of gout patients, febuxostat (Uloric®) and allopurinol.
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing extended-release tablets containing 2.5mg, 5mg and 10mg Felodipine, which are used in treating hypertension.
› Verified 1 days ago
Joyline D James, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 3400 Lebanon Rd, Murfreesboro, TN 37129 Phone: 615-867-6000 | |
Vishant Shah, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3400 Lebanon Rd, Murfreesboro, TN 37129 Phone: 615-225-2493 | |
Dr. Valarie Readus Moore, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 3400 Lebanon Road, Murfreesboro, TN 37129 Phone: 615-867-6000 | |
Richard Earl Parrish, MD, FCCP Nephrology Medicare: Medicare Enrolled Practice Location: 1800 Medical Center Pkwy Ste 310, Murfreesboro, TN 37129 Phone: 615-849-9868 Fax: 615-898-1882 | |
Joseph Scott, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1272 Garrison Drive, Murfreesboro, TN 37129 Phone: 615-867-8010 Fax: 615-867-7945 | |
Dr. Vlada Melekhin, M.D., M.P.H. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy Ste 400, Murfreesboro, TN 37129 Phone: 615-396-6800 | |
Dr. Donald Parker Patterson, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Parkway, Depaul Bldg. Ste. 400, Murfreesboro, TN 37129 Phone: 615-396-6800 Fax: 615-396-6801 |